Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    January 2010
  1. TAN EK , Ho P, Tan L, Prakash KM, et al
    PLA2G6 mutations and Parkinson's disease.
    Ann Neurol. 2010;67:147-8.
    PubMed     Text format     Related articles   


    December 2009
  2. BALLANGER B , van Eimeren T, Moro E, Lozano AM, et al
    Stimulation of the subthalamic nucleus and impulsivity: release your horses.
    Ann Neurol. 2009;66:817-24.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  3. DAHODWALA N , Xie M, Noll E, Siderowf A, et al
    Treatment disparities in Parkinson's disease.
    Ann Neurol. 2009;66:142-145.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  4. OLANOW CW , Kordower JH
    Modeling Parkinson's disease.
    Ann Neurol. 2009;66:432-436.
    PubMed     Text format     Related articles   


  5. JOHNSTON SC , Hauser SL
    Disparities in care: guilty until proven innocent.
    Ann Neurol. 2009;66:A7-8.
    PubMed     Text format     Related articles   


    July 2009
  6. LIM AS , Moro E, Lozano AM, Hamani C, et al
    Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons.
    Ann Neurol. 2009;66:110-4.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  7. OLANOW CW , Kordower JH, Lang AE, Obeso JA, et al
    Dopaminergic transplantation for parkinson's disease: Current status and future prospects.
    Ann Neurol. 2009;66:591-596.
    PubMed     Text format     Related articles    Abstract available


  8. ELSTNER M , Morris CM, Heim K, Lichtner P, et al
    Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene.
    Ann Neurol. 2009;66:792-798.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  9. ELBAZ A , Clavel J, Rathouz PJ, Moisan F, et al
    Professional exposure to pesticides and Parkinson disease.
    Ann Neurol. 2009;66:494-504.
    PubMed     Text format     Related articles    Abstract available


  10. MCNAUGHT KS , Olanow CW
    Retraction. Proteasome inhibitor-induced model of Parkinson's disease (Ann Neurol 2006;60:243-247).
    Ann Neurol. 2009;65:485.
    PubMed     Text format     Related articles   


    March 2009
  11. TINSLEY RB , Bye CR, Parish CL, Tziotis-Vais A, et al
    Dopamine D(2) receptor knockout mice develop features of Parkinson disease.
    Ann Neurol. 2009;66:472-484.
    PubMed     Text format     Related articles    Abstract available


  12. HERRERO HERNANDEZ E
    Pigmentation as a clue to understanding Parkinson's disease and melanoma.
    Ann Neurol. 2009;65:759.
    PubMed     Text format     Related articles   


  13. GARCIA-GOROSTIAGA I , Sanchez-Juan P, Mateo I, Rodriguez-Rodriguez E, et al
    Glycogen synthase kinase-3beta and tau genes interact in Parkinson's and Alzheimer's diseases.
    Ann Neurol. 2009;65:759-761.
    PubMed     Text format     Related articles   


  14. GAGNON JF , Vendette M, Postuma RB, Desjardins C, et al
    Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.
    Ann Neurol. 2009;66:39-47.
    PubMed     Text format     Related articles    Abstract available


  15. WEINER W , Ahlskog E, Factor S, Suchowersky O, et al
    Initiating therapy in Parkinson's disease.
    Ann Neurol. 2009;65:480-481.
    PubMed     Text format     Related articles   


  16. MONTGOMERY EB JR
    Basal ganglia pathophysiology in Parkinson's disease.
    Ann Neurol. 2009;65:618.
    PubMed     Text format     Related articles   


  17. OKUN MS , Fernandez HH, Wu SS, Kirsch-Darrow L, et al
    Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial.
    Ann Neurol. 2009.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  18. GAO X , Simon KC, Han J, Schwarzschild MA, et al
    Genetic determinants of hair color and parkinson's disease risk.
    Ann Neurol. 2009;65:76-82.
    PubMed     Text format     Related articles    Abstract available


  19. HAYFLICK SJ
    Dystonia-parkinsonism disease gene discovery: Expect surprises.
    Ann Neurol. 2009;65:2-3.
    PubMed     Text format     Related articles   


    January 2009
  20. MAREK K , Jennings D, Tamagnan G, Seibyl J, et al
    Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  21. GUPTA A , Dawson VL, Dawson TM
    What causes cell death in Parkinson's disease?
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  22. JENNER P
    Functional models of Parkinson's disease: A valuable tool in the development of novel therapies.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  23. OBESO JA , Marin C, Rodriguez-Oroz C, Blesa J, et al
    The basal ganglia in Parkinson's disease: Current concepts and unexplained observations.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  24. ISACSON O , Kordower JH
    Future of cell and gene therapies for Parkinson's disease.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  25. SIMUNI T , Sethi K
    Nonmotor manifestations of Parkinson's disease.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  26. SIDEROWF A , Stern MB
    Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  27. OLANOW CW , Kieburtz K, Schapira AH
    Why have we failed to achieve neuroprotection in Parkinson's disease?
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  28. SCHAPIRA AH , Olanow CW
    Drug selection and timing of initiation of treatment in early Parkinson's disease.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  29. GOETZ CG , Emre M, Dubois B
    Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  30. FAHN S
    How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


  31. OLANOW CW , Stern MB
    Parkinson's disease: Unresolved issues.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles   


  32. WEINTRAUB D
    Dopamine and impulse control disorders in Parkinson's disease.
    Ann Neurol. 2009;64.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  33. BURKE RE , Dauer WT, Vonsattel JP
    A critical evaluation of the braak staging scheme for Parkinson's disease.
    Ann Neurol. 2008;64:485-491.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  34. SETHI NK , Sethi PK
    Evidence-based medicine vs medicine-based evidence.
    Ann Neurol. 2008;64:592.
    PubMed     Text format     Related articles   


    October 2008
  35. TAN EK , Tang M, Tan LC, Wu YR, et al
    Lrrk2 R1628P in non-Chinese Asian races.
    Ann Neurol. 2008;64:472-3.
    PubMed     Text format     Related articles   


    June 2008
  36. PAISAN-RUIZ C , Bhatia KP, Li A, Hernandez D, et al
    Characterization of PLA2G6 as a locus for dystonia-parkinsonism.
    Ann Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  37. ROSS OA , Braithwaite AT, Skipper LM, Kachergus J, et al
    Genomic investigation of alpha-synuclein multiplication and parkinsonism.
    Ann Neurol. 2008;63:743-50.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  38. ROSS OA , Wu YR, Lee MC, Funayama M, et al
    Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ann Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


    March 2008
  39. JANKOVIC J
    Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
    Ann Neurol. 2008;63:267-9.
    PubMed     Text format     Related articles   


    February 2008
  40. LEWITT PA , Guttman M, Tetrud JW, Tuite PJ, et al
    Adenosine A(2A) receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005).
    Ann Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  41. ALBERS MW , Marder KS
    A tale of two etiologies: loss and recovery of olfactory function.
    Ann Neurol. 2008;63:132-4.
    PubMed     Text format     Related articles   


    January 2008
  42. MARTIN WR , Wieler M, Stoessl AJ, Schulzer M, et al
    Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Ann Neurol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  43. DOTY RL
    The olfactory vector hypothesis of neurodegenerative disease: is it viable?
    Ann Neurol. 2008;63:7-15.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: